Tocopherols (e.g., Vitamin E, Etc.) Patents (Class 514/458)
-
Patent number: 9345685Abstract: The present invention relates to compositions comprising a combination of PKC activators and PKC inhibitors and methods to modulate ?-secretase activity; improve or enhance cognitive ability; and or reduce neurodegeneration in individuals suffering from diseases that impair cognitive ability, particularly Alzheimer's Disease. The invention also relates to methods for improving or enhancing cognitive ability. The present invention also provides methods for increasing the generation of non-amyloidogenic soluble APP (sAPP) comprising the activation of protein kinase C (PKC) in the brain and inhibiting PKC in peripheral tissues. Macrocyclic lactones (i.e. bryostatin class and neristatin class) are preferred PKC activators and Vitamin E is a preferred PKC inhibitor for use in the inventive composition.Type: GrantFiled: September 16, 2010Date of Patent: May 24, 2016Assignee: Blanchette Rockefeller Neuroscience InstituteInventor: Daniel Alkon
-
Patent number: 9271956Abstract: A composition includes dihydroquercetin, ?-tocopherol and bisabolol. The use of the composition in a cosmetic method for limiting, alleviating and/or preventing cutaneous discomfort, especially cutaneous discomfort induced by a disease or induced by a therapy, a radiotherapy treatment and/or chemotherapy treatment, and the process of manufacturing the composition are also described.Type: GrantFiled: August 20, 2013Date of Patent: March 1, 2016Assignee: BIONOOX SUISSE SAInventor: Christian Auclair
-
Patent number: 9254304Abstract: The present invention relates to a dietary supplement composition made of: linolenic expeller pressed soybean oil in the range of 65%-85%, Omega 3 (18/12) fish oil 15%-35%, 1%-20% alpha-tocopherol, and 7.5%-15% acai berry powder and a method to use this composition to supplement the diet of a domestic animal, such as a canine or an equine.Type: GrantFiled: March 27, 2014Date of Patent: February 9, 2016Assignee: O3 Animal Health, LLCInventor: Murray Fulgham
-
Patent number: 9248155Abstract: The present invention relates to a dietary supplement composition made of: linolenic expeller pressed soybean oil in the range of 65%-85%, Omega 3 (18/12) fish oil 15%-35%, and 1%-20% alpha-tocopherol and a method to use this composition to supplement the diet of a domestic animal, such as a canine or an equine.Type: GrantFiled: March 27, 2014Date of Patent: February 2, 2016Assignee: O3 Animal Health, LLCInventor: Murray Fulgham
-
Patent number: 9199101Abstract: The invention relates to the cosmetic use of a peptide hydrolysate of pea (Pisum sativum L.), as skin-moisturizing active agent. The invention also relates to the use of a cosmetic composition comprising an effective amount of active agent according to the invention in a physiologically acceptable medium, for preventing dryness of the skin or restoring moisturization of the skin. The invention also relates to the use of this novel active agent for preparing a pharmaceutical, in particular dermatological, composition intended for treating pathological dryness of the skin.Type: GrantFiled: April 14, 2011Date of Patent: December 1, 2015Assignee: ISP INVESTMENTS INC.Inventors: Claude Dal Farra, Nouha Domloge, Jean-Marie Botto
-
Patent number: 9144566Abstract: The present invention provides for compositions, medicaments, and methods for treating or alleviating the symptoms of dry eye syndrome or chronic dry eye. More specifically, the present embodiments provide for medicaments consisting of tocopherol or tocotrienol eyedrops. A single topical administration of tocopherol or tocotrienol eyedrops in the eyes of a subject suffering from dry eye alleviates symptoms for at least one day. In particular, the eyedrop medicament consists of ?-tocopheryl acetate; ?-tocopheryl acetate and about 0.5% aqueous component; or ?-tocopheryl acetate, about 2.5% tocopherol emulsifier, and about 20% to about 30% aqueous excipient.Type: GrantFiled: March 18, 2014Date of Patent: September 29, 2015Assignee: Ramscor, Inc.Inventors: Vernon G. Wong, Louis L. Wood
-
Patent number: 9066904Abstract: A composition useful for maintaining healthy levels of testosterone in men and women. The composition includes essential oils from a tree of the genus Picea or a product of this oil. The essential oil product can specifically come from essential oil from the plant Picea pungens, commonly referred to as Blue Spruce. Also disclosed is a method for maintaining healthy levels of testosterone in men and women utilizing the composition. In some implementations, the composition is a pharmaceutical composition that further includes a penetration enhancer. A method for utilizing the pharmaceutical composition for treating hypogonadism is also disclosed.Type: GrantFiled: November 14, 2013Date of Patent: June 30, 2015Assignee: Young Living Essential Oils, LCInventor: D. Gary Young
-
Patent number: 9044451Abstract: This disclosure relates generally to the treatment of lysosomal storage disorders. Specifically, the disclosure relates to a novel use of delta tocopherol in the treatment of diseases and conditions related to lysosomal storage disorders. Included in the present disclosure is a method for the modulation of cholesterol recycling. Further, the disclosure relates to conditions such as Niemann-Pick type C disease, Farber disease, Niemann-Pick type A disease, Wolman disease and Tay Sachs disease. Further included in the present disclosure is a method for treating lysosomal storage disorders comprising the administration of delta tocopherol. Further included in the present disclosure is a method for treating lysosomal storage disorders comprising the administration of delta tocopherol in combination with cyclodextrin to a patient in need thereof.Type: GrantFiled: July 19, 2011Date of Patent: June 2, 2015Assignee: The United States of America, as represented by the Secretary, Department of Health and Human ServicesInventors: Wei Zheng, Juan Jose Marugan, Ke Liu, Noel Terrence Southall, Christopher P Austin
-
SPINAL CORD INJURY, INFLAMMATION, AND IMMUNE-DISEASE: LOCAL CONTROLLED RELEASE OF THERAPEUTIC AGENTS
Publication number: 20150148317Abstract: A drug delivery system is provided for treatment of oxidative stress. The drug delivery system can include a therapeutic agent and a matrix. The therapeutic agent can include an antioxidant or steroid. The matrix can include a hydrogel, particle, microparticle, or nanoparticle. A method of treating injury, including peripheral nerve injury or spinal cord injury, is also provided. The method includes injecting the drug delivery system at the site of injury.Type: ApplicationFiled: November 26, 2014Publication date: May 28, 2015Applicants: InVivo Therapeutics Corporation, Massachusetts Institute of TechnologyInventors: Christopher D. Pritchard, Robert S. Langer, Francis M. Reynolds, Eric J. Woodard -
Patent number: 9040066Abstract: This invention is based upon the discovery that a mixture of ethyl lactate and isoamyl lactate can be used to improve the penetration of active ingredients in skin care formulations through the outer layers of the stratum corneum and viable epidermis and into the dermis layer of the skin structure. The present invention more specifically discloses a method of rejuvenating skin comprising topically applying a topical formulation to the skin, wherein the topical formulation is comprised of ascorbic acid, an amino acid selected from the group consisting of phenylalanine and tyrosine, a non-toxic zinc salt, carnosic acid, ?-tocopherol, 0.01 weight percent to 20 weight percent of a mixture of ethyl lactate and isoamyl lactate, wherein the weight ratio of the ethyl lactate to the isoamyl lactate is within the range of 1:10 to 20:1, and a pharmaceutically acceptable carrier.Type: GrantFiled: April 7, 2014Date of Patent: May 26, 2015Assignee: Ad Lunam Labs, Inc.Inventors: William H. Beeson, Alvin T. Rockhill
-
Publication number: 20150139973Abstract: The present invention relates to an ophthalmological vehicle system for the permeation and/or for the active substance transport of ophthalmological active substances through the cornea and/or the sclera of the eye of mammals. This vehicle system assists the transport of the active substances through the cornea and/or the sclerotic tissue of the eye. The vehicle system is suitable for the prophylaxis and/or treatment of diseases of the front and/or back portion of the eye. Likewise, the present invention relates to an ophthalmological kit, comprising a special ophthalmological composition and also, as separate formulation, an ophthalmological active substance.Type: ApplicationFiled: May 14, 2013Publication date: May 21, 2015Inventors: Ute Steinfeld, Frank Holzer, Hyeck Hee Lee, Markus Mahler
-
Publication number: 20150139938Abstract: The present invention provides methods of promoting arteriogenesis in a subject. Embodiments include methods comprising: administering an effective dose of tocotrienol to the subject; causing an increase in Tissue Inhibitor of Metalloproteinase Metallopeptidase Inhibitor 1 (TIMP1) in vessels of cerebrovascular collateral circulation in the subject; attenuating the activity of Matrix Metalloproteinase-2 (MMP2); thereby promoting arteriogenesis.Type: ApplicationFiled: June 7, 2013Publication date: May 21, 2015Applicant: Ohio State Innovation FoundationInventors: Chandan Sen, Cameron Rink, Sashwati Roy, Greg Christoforidis
-
Patent number: 9034919Abstract: This invention relates generally to the field of compositions for use as nutraceuticals, food additives or adjuncts to conventional drug therapies. In particular, the invention relates to compositions derived from natural oil sources which can be used for effective and inexpensive treatment of cardiovascular diseases, hypercholesterolemia, diabetes, cerebrovascular disease, neurological disorders, or liver abnormalities.Type: GrantFiled: April 18, 2006Date of Patent: May 19, 2015Inventors: Aravind Cherukuri, Reddy Sastry V. Cherukuri, Rukmini C. Cherukuri, Kartik Natarajan
-
Patent number: 9034383Abstract: The present invention provides nanoparticulate policosanol, and octacosanol formulations including these particles, as a well as methods of using the particles and formulations for treatment and prophylaxis of various diseases and conditions.Type: GrantFiled: August 16, 2011Date of Patent: May 19, 2015Assignee: NanoRx, Inc.Inventor: Palayakotai R. Raghavan
-
Publication number: 20150118298Abstract: Described herein are pharmaceutical compositions comprising polyunsaturated fatty acids and methods of manufacturing the same. In particular, described herein are pharmaceutical compositions comprising soft enteric capsules comprising omega-3 polyunsaturated fatty acids. The oral pharmaceutical compositions described herein are useful as nutritional supplements or for the treatment of cardiovascular-related diseases, such as hyper dyslipidemia and high triglyceride levels.Type: ApplicationFiled: October 29, 2014Publication date: April 30, 2015Inventors: Peijin Zhang, Aqeel A. Fatmi
-
Patent number: 9011915Abstract: This invention provides for biocompatible and biodegradable syringeable liquid, implantable solid, and injectable gel pharmaceutical formulations useful for the treatment of systemic and local disease states.Type: GrantFiled: January 14, 2011Date of Patent: April 21, 2015Assignee: Ramscor, Inc.Inventors: Vernon G. Wong, Louis L. Wood
-
Publication number: 20150094292Abstract: Activated fatty acids, topical compositions including activated fatty acids and methods for using activated fatty acids to treat a variety of diseases.Type: ApplicationFiled: December 8, 2014Publication date: April 2, 2015Inventor: Raymond A. Miller
-
Publication number: 20150086625Abstract: Activated fatty acids, nutraceutical compositions including activated fatty acids, methods for using activated fatty acids to treat a variety of diseases, and methods for preparing activated fatty acids are provided herein.Type: ApplicationFiled: December 8, 2014Publication date: March 26, 2015Inventor: Raymond A. Miller
-
Publication number: 20150079176Abstract: A uniform microfluidized nanoemulsion is disclosed containing a synergistic combination of two antioxidants and a cell membrane stabilizer phospholipid (i.e., an anti-oxidant synergy formulation; ASF). The microfluidized nanoemulsion improves the combination's cell membrane permeability by at least four-fold over conventional nanoemulsion compositions, which significantly increases the intracellular concentration of typically cell-impermeant antixoidants (i.e., for example, tocopherol) and/or systemic bioavailability. As a nanoemulsion, synergistic combination has greater anticancer efficacy than the same combination applied as a free solution.Type: ApplicationFiled: July 30, 2014Publication date: March 19, 2015Inventors: Robert Nicolosi, Thomas Shea
-
Patent number: 8969303Abstract: Esters of tocotrienols having pharmacological activities pertinent to the treatment of breast cancer and other forms of cancer are disclosed herein. Among those compounds is (Z)-4-oxo-4-((R)-2,5,7,8-tetramethyl-2-((3E,7E)-4,8,12-trimethyltrideca-3,7,11-trienyl)chroman-6-yloxy)but-2-enoic acid. Tocotrienol esters were used to inhibit the growth and migration of +SA mammary epithelial cells and highly metastatic human breast cancer MDA-MB-231 cells respectively.Type: GrantFiled: February 4, 2011Date of Patent: March 3, 2015Assignee: First Tech International LimitedInventors: Khalid A. El Sayed, Paul W. Sylvester
-
Publication number: 20150051274Abstract: The present invention relates to a dietary supplement composition made of: linolenic expeller pressed soybean oil in the range of 65%-85%, Omega 3 (18/12) fish oil 15%-35%, and 1%-20% alpha-tocopherol and a method to use this composition to supplement the diet of a domestic animal, such as a canine or an equine.Type: ApplicationFiled: March 27, 2014Publication date: February 19, 2015Applicant: EQUINE MEGA-OMEGA, LLCInventor: Murray Fulgham
-
Patent number: 8957110Abstract: The invention concerns topical compositions for the prevention and treatment of ocular pathologies, in particular inflammatory keratites and conjunctivites and dry eye syndrome, containing as active ingredients polyunsaturated fatty acids of the types omega-3 and omega-6, and specifically EPA (eicosapentaenoic acid), DHA (docosahexaenoic acid) and GLA (?-linolenic acid), mixed with vitamin E acetate and formulated in a stable composition in hydrogel, i.e. in dispersed form in an aqueous vehicle containing one or more gelling polymers. The proposed compositions are particularly indicated for use as artificial tears.Type: GrantFiled: March 18, 2010Date of Patent: February 17, 2015Assignee: TRB Chemedica International S.A.Inventors: Danilo Aleo, Stefano Barabino, Sergio Mangiafico, Maurizio Rolando, Maria Grazia Antonietta Saita
-
Publication number: 20150025133Abstract: Disclosed are nutritional formulas generally, and infant formulas specifically, including a combination of RRR-alpha tocopherol, LC-PUFAs, and optionally vitamin C. The combination enhances brain development and improves cognitive performance in an individual, and specifically in an infant.Type: ApplicationFiled: March 7, 2013Publication date: January 22, 2015Applicant: ABBOTT LABORATORIESInventors: Chron-Si Lai, Matthew J. Kuchan, Daniel S. Albrecht
-
Publication number: 20150025097Abstract: The present disclosure relates to methods of retarding hair loss or facilitating hair growth and/or regrowth. More specifically, the present disclosure relates to methods of using the disclosed compositions to increase the rate of terminal hair growth and/or regrowth in a mammal.Type: ApplicationFiled: October 10, 2014Publication date: January 22, 2015Inventors: Longsheng Hu, Virginia Streusand Goldman, Josephine A. Minerva, Susan Wendling
-
Publication number: 20150010549Abstract: The present invention relates to use of DHA analogs and their pharmaceutical compositions for treating ALS, by administering these compounds or pharmaceutical compositions to subjects in need thereof.Type: ApplicationFiled: February 15, 2013Publication date: January 8, 2015Applicant: ANIDA PHARMA INC.Inventor: Per Gjorstrup
-
Publication number: 20150010606Abstract: Formulations, mixtures, compositions and techniques for improved treatment options for osteoarthritis and intra-articular joint degeneration. The formulations and compositions are provided in the form of injectable aqueous formulations that increase the delivery of a lubricating agent (lubrication molecules) into the joint to resist breakdown, decrease free radical production (by neutralizing these radicals), and increase removal of superoxide byproducts in the synovial fluid. The injectable aqueous formulations are preferably administered into the intra-articular space of an intra-articular joint. The lubricating formulation includes molecules of lubricin and SOD, hyaluronic acid and SOD, or lubricin and SOD and hyaluronic acid, or hyaluronic acid and lubricin, or Vitamin E and SOD or hyaluronic acid, or combinations thereof.Type: ApplicationFiled: July 3, 2014Publication date: January 8, 2015Inventors: Brandon L. Roller, Christopher M. Bare, Tithi Dutta Roy, Ricardo Albertorio
-
Publication number: 20150011488Abstract: Epicatechins, Epicatechin Oligomers, or Thiolated Epicatechins are applied (A) directly to a genital wart in the form of a cream, ointment, paste or solution, (B) directly to the genital wart wherein such cream, ointment, paste or solution contains as an additional active ingredient a skin permeabilizing agent, (C) following electrosurgical resection or removal of the genital wart in such form of a cream, ointment, paste or solution, (D) following chemical resection or extirpation of the genital wart in such form, (E) following surgical resection or removal of the genital wart in such form, wherein said Epicatechins, Epicatechin Oligomers, or Thiolated Epicatechins both provide antiviral activity against multiple strains of human pappilomavirus (HPV) and promote healing following resection polymers contained in a vehicle. Disclosed are the compositions, therapeutical kits containing such composition, methods of treatment using such composition, and methods of enhancing the stability of such composition.Type: ApplicationFiled: March 10, 2014Publication date: January 8, 2015Applicant: CACAO BIO-TECHNOLOGIES, LLCInventors: Daniel PRESTON, Randall B. MURPHY
-
Patent number: 8927528Abstract: A composition to be administered to a mammal for treating hearing loss is disclosed herein. The composition consists essentially of a biologically effective amount of vitamin A, vitamin C, vitamin E, and a vasodilator comprising magnesium. The composition optionally includes a withanolide and/or resveratrol. The vitamin A, vitamin C, vitamin E, and the vasodilator comprising magnesium provides an additive effect that is equal to or greater than a sum of the effects of the individual components.Type: GrantFiled: November 16, 2012Date of Patent: January 6, 2015Assignee: The Regents of the University of MichiganInventors: Josef Miller, Colleen LePrell, Jochen Schact, Diane Prieskorn
-
Patent number: 8927554Abstract: The present disclosure relates to compositions containing certain pyrimidine compounds such as minoxidil and/or certain pyrimidine sulfate (inner salt) compounds such as minoxidil sulfate and especially compositions containing pyrimidine compounds in combination with an admixtures comprising at least one antioxidant, at least one organic acid and a select fatty acid mixture. The present disclosure also relates to use of the compositions to grow and/or regrow hair and/or prevent hair loss in mammals and particularly in humans.Type: GrantFiled: May 15, 2012Date of Patent: January 6, 2015Assignee: McNeil-PPC, Inc.Inventors: Longsheng Hu, Virginia Streusand Goldman, Josephine A. Minerva, Susan Wendling
-
Publication number: 20150004238Abstract: Stable vitamin oil-in-water emulsions and methods of making those emulsions are described herein. The emulsions may be used to make beverage products that include fat-soluble vitamins. The emulsions may also be used in beverage products that are colored and which maintain color stability for an extended period of time.Type: ApplicationFiled: August 5, 2014Publication date: January 1, 2015Inventors: Archana N.M.I. Khangaonkar, Jeffrey D. Nutt
-
Patent number: 8916171Abstract: A medication or combination of medications for the treatment of a disease involving the sinuses is incorporated into a sterile medical gel. The viscosity of the gel or the adhesion of the gel to the patient's sinus cavity allows the gel to be maintained in the cavity for a sufficient length of time for treatment of the affected area. This reduces the amount of wasted medication that would otherwise result from other topical methods.Type: GrantFiled: April 27, 2011Date of Patent: December 23, 2014Assignee: Topical Sinus Therapeutics, Inc.Inventors: Russell N. Reitz, Robert Scott Osbakken
-
Publication number: 20140370103Abstract: This disclosure provides microparticles for the delivery of non-immunogenic compositions providing delivery of ?-, ?- and/or ?-tocopherols.Type: ApplicationFiled: September 3, 2014Publication date: December 18, 2014Inventor: Bin Wu
-
Publication number: 20140363523Abstract: The present invention provides a compound of Formula (I), wherein: each X is independently hydrogen or deuterium; and at least one X is deuterium.Type: ApplicationFiled: January 17, 2013Publication date: December 11, 2014Inventor: Adam Morgan
-
Patent number: 8906960Abstract: A transdermal fluid is provided wherein the main ingredient is tocotrienol and curcumin is added to enhance the anti-cancer effects of tocotrienols. The composition is useful for the treatment or prevention of a cancer, a tumor or an inflammatory disorder, particularly breast cancer.Type: GrantFiled: March 8, 2011Date of Patent: December 9, 2014Assignee: Malaysian Palm Oil BoardInventors: Kalanithi Nesaretnam, Kanga Rani Selvaduray
-
Publication number: 20140357709Abstract: (Modified) sorghum protein is used as novel protective hydrocolloid for active ingredients, especially fat-soluble active ingredients and/or colorants. Included are compositions comprising (modified) sorghum protein and at least one active ingredient and to their manufacture, as well as to the (modified) sorghum protein itself and its manufacture. These compositions are used for the enrichment, fortification and/or coloration of food, beverages, animal feed, personal care or pharmaceutical compositions, and to food, beverages, animal feed, personal care and pharmaceutical compositions containing such a (modified) sorghum protein and such a composition, respectively.Type: ApplicationFiled: August 13, 2014Publication date: December 4, 2014Applicant: DSM IP ASSETS B.V.Inventor: Christian SCHAEFER
-
Patent number: 8901107Abstract: A composition which includes a salt of metformin and the use of the composition for treatment of or use in prediabetes, diabetes, lowering triglycerides and/or other conditions in mammals.Type: GrantFiled: June 21, 2013Date of Patent: December 2, 2014Assignee: Thetis Pharmaceuticals LLCInventors: Banavara L. Mylari, Frank C. Sciavolino
-
Patent number: 8901168Abstract: The invention relates to a formulation for supplementation on immune response to a biological substance. More particularly, the formulation consists of one or more forms of Vitamin E which provides a supplementation on immune response to tetanus toxoid. In addition, the present invention also relates on the effect of different types of Vitamin E such as tocotrienol rich fraction, delta tocotrienol and alpha-tocopherol supplementation on immune response to tetanus toxoid vaccination.Type: GrantFiled: October 1, 2008Date of Patent: December 2, 2014Inventor: Kalanithi Nesaretnam
-
Publication number: 20140348910Abstract: The present invention relates to topical formulations that include lipid microcapsules formed from tocopherol, tocotrienol, or mixtures thereof; a stabilizer/surfactant component; and an aqueous component. The lipid microcapsules may be formed without the use of steroids, preservatives, initiators and/or oils. The topical formulations are capable of delivering transdermal active agent(s) such as vitamin D through the skin and into the bloodstream without the use of skin penetration enhancers. In certain embodiments, the topical formulations also able to deliver topical active agent(s) such as sun-protecting agents to the surface of the skin where they remain, while simultaneously delivering the transdermal active agent(s) through the skin and into the bloodstream.Type: ApplicationFiled: June 29, 2012Publication date: November 27, 2014Applicant: AVIDAS PHARMACEUTICALS LLCInventor: David Craig Wright
-
Patent number: 8894978Abstract: A new skin care system includes day and night skin cream compositions comprising nutrients and antioxidants for use by children between six months and eighteen years of age. The day skin cream composition provides protection from UV radiation and the night skin cream composition contains no sun protection ingredients and elevated levels of nutrients and antioxidants. A child-friendly bottle for each composition can be used by young children without difficulty. A fragrance included in each composition is popular with children, and the bottle for the day composition has graphics indicating day-time use and the bottle for the night composition has graphics indicating night-time use. The day composition is applied topically each day to the face after tooth-brushing, and the night composition is applied topically to the face each night after tooth-brushing.Type: GrantFiled: April 25, 2014Date of Patent: November 25, 2014Inventor: William Scott Prendergast
-
Patent number: 8889194Abstract: Disclosed is a compound and methods for use by an individual attempting to reduce or cease tobacco smoking or one exposed to environmental tobacco smoke. The compound includes a first component blocking nicotine receptor sites to reduce nicotine cravings or withdrawal symptoms, a second component increasing serotonin levels and acting synergistically with the first component to reduce nicotine cravings or withdrawal symptoms, assisting in maintaining body weight and reducing increased stress and anxiety, and a third component acting synergistically with the first and/or second component to reduce nicotine cravings or withdrawal symptoms, maintain body weight, and/or reduce increased stress and anxiety. The third component comprises a supplement that replenishes depleted body substance(s), repairs damaged body substance(s), and/or ameliorates the impaired function of body substance(s). Some combination of the first, second, and third component alters the perceived taste of tobacco smoke.Type: GrantFiled: September 29, 2010Date of Patent: November 18, 2014Inventor: Harlan Clayton Bieley
-
Patent number: 8883221Abstract: Micronutrient combination product, wherein the micronutrient combination product comprises zeaxanthin, lutein, zinc and copper.Type: GrantFiled: December 17, 2004Date of Patent: November 11, 2014Assignee: Bausch & Lomb IncorporatedInventors: Guenter Bellmann, Gudrun Claus-Herz
-
Publication number: 20140328885Abstract: Sheet for cutaneous application comprising a support layer made of loosely woven fabric embedded in a layer of silicone elastomer incorporating vitamin E or an ester thereof, wherein the layer of silicone elastomer has a thickness less than or equal to 2.0 mm and the silicone elastomer contains an elasticity modifier consisting of a triglyceride of saturated C8-C18 fatty acids.Type: ApplicationFiled: May 24, 2013Publication date: November 6, 2014Applicant: IneSalus Corp.Inventor: Giorgio Panin
-
Publication number: 20140328775Abstract: A cosmetic composition suitable for topical application, for example, is provided. In some examples, the cosmetic composition may include batyl alcohol, undecylenoyl phenylalanine, hexyldecanol, and bisabolol. A method of reducing the synthesis of melanin by using the cosmetic compositions is also disclosed herein.Type: ApplicationFiled: May 1, 2014Publication date: November 6, 2014Applicant: The Procter & Gamble CompanyInventors: Leo Timothy LAUGHLIN, II, Tomohiro HAKOZAKI, Shuhei TANAKA
-
Patent number: 8877746Abstract: Compositions and methods of making the same for in vivo delivery of lixivaptan to a subject in need thereof are described. The composition includes a substantially water-insoluble pharmacologically active agent (e.g., lixivaptan) and a substantially water-insoluble matrix forming material (e.g., a Vitamin E semi-ester), wherein the pharmacologically active agent is dispersed in said matrix forming material, and wherein the composition delivers said substantially water-insoluble pharmacologically active agent upon exposure to physiological medium.Type: GrantFiled: August 24, 2010Date of Patent: November 4, 2014Assignee: Cardioklne, IncInventors: Hailiang Chen, Andrew Xian Chen, Patricia Frech, Khawla Abu-Izza, Christoph Schmidt
-
Publication number: 20140322340Abstract: The present invention provides protein (or peptide)-polysaccharide (or oligosaccharide) conjugates (PPC) as nanocapsular vehicles for nanoencapsulation of biologically active compounds, particularly nutraceuticals. The PPCs efficiently protect both hydrophobic (i.e., water insoluble) and hydrophilic (i.e., water soluble) nutraceuticals, to provide a composition which, when added to a beverage, disperses so as to provide a clear or transparent solution. In some embodiments, the PPCs are Maillard reaction based PPCs. Advantageously, the conjugates of the present invention protect the nutraceuticals from degradation, both during shelf life and upon gastric digestion.Type: ApplicationFiled: May 4, 2014Publication date: October 30, 2014Applicant: Technion Research and Development Foundation LTD.Inventor: Yoav D. Livney
-
Publication number: 20140323505Abstract: An oral rinse composition that comprises an aqueous solution that includes a high molecular weight polymer and an energy supplement that stimulates central nervous system activity.Type: ApplicationFiled: April 24, 2014Publication date: October 30, 2014Applicant: Rinsenergy LLCInventors: Howard Ketelson, David Meadows, Rekha Rangarajan, Yen Tran
-
Publication number: 20140323412Abstract: Provided herein are methods of treating or ameliorating hypercholemia or a cholestatic liver disease by administering to an individual in need thereof a therapeutically effective amount of an Apical Sodium-dependent Bile Acid Transporter Inhibitor (ASBTI) or a pharmaceutically acceptable salt thereof. Also provided are methods for treating or ameliorating a liver disease, decreasing the levels of serum bile acids or hepatic bile acids, treating or ameliorating pruritis, reducing liver enzymes, or reducing bilirubin comprising administering to an individual in need thereof a therapeutically effective amount of ASBTI or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: October 26, 2012Publication date: October 30, 2014Inventors: Bronislava Gedulin, Michael Grey, Niall O'Donnell
-
Patent number: 8871773Abstract: The present disclosure relates to methods of retarding hair loss or facilitating hair growth and/or regrowth. More specifically, the present disclosure relates to methods of using the disclosed compositions to increase the rate of terminal hair growth and/or regrowth in a mammal.Type: GrantFiled: June 3, 2013Date of Patent: October 28, 2014Assignee: McNeil-PPC, Inc.Inventors: Longsheng Hu, Virginia Streusand Goldman, Josephine A. Minerva, Susan Wendling
-
Publication number: 20140315995Abstract: The invention provides non-irritating, stable topical compositions including at least Vitamin C, Vitamin E and a polyphenol antioxidant. Such compositions can be used to facilitate the prevention or treatment of free oxygen, nitrogen, and/or other free radical related skin damage. Also provided are methods for modifying free radical damage to skin by administering such compositions in an amount sufficient to treat and/or prevent free radical damage to the skin.Type: ApplicationFiled: April 22, 2014Publication date: October 23, 2014Inventor: Frank Dreher
-
Publication number: 20140308376Abstract: The present invention relates to compositions useful in treating hyperpigmentation and the various signs of dermatological aging in human skin. The present invention also relates to cosmetic compositions and methods of using such compositions that improve the aesthetic appearance of skin. Further, the present invention relates to methods of applying the compositions to the skin to effect treatment and to improve the aesthetic appearance of skin, particularly, by providing anti-aging benefits to the skin.Type: ApplicationFiled: June 30, 2014Publication date: October 16, 2014Inventors: Harish Mahalingam, Christos D. Kyrou, Michael Traudt, Dmitri S. Ptchelintsev